title: Fluorescence in situ hybridization as a tool to characterize genetic alterations in pancreatic adenocarcinoma.
authors.forename: Muriel
authors.initials: M
authors.lastname: Genevay
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Dumonceau
authors.forename: Béatrice
authors.initials: B
authors.lastname: Pepey
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Pache
authors.forename: Laura
authors.initials: L
authors.lastname: Rubbia-Brandt
authors.forename: Thomas Alexander
authors.initials: TA
authors.lastname: McKee
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics*; D002869:Chromosome Aberrations; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D051901:Smad4 Protein / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc; C497796:SMAD4 protein, human; D051901:Smad4 Protein; D016159:Tumor Suppressor Protein p53